Compare NBTX & ZD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | ZD |
|---|---|---|
| Founded | 2003 | 1995 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2018 | 1999 |
| Metric | NBTX | ZD |
|---|---|---|
| Price | $27.39 | $54.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $54.44 | ★ $63.67 |
| AVG Volume (30 Days) | 114.9K | ★ 531.8K |
| Earning Date | 09-24-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 17.49 |
| Revenue | N/A | ★ $1,364,028,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $50.69 | $1.46 |
| P/E Ratio | ★ N/A | $3.22 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.78 | $22.45 |
| 52 Week High | $57.14 | $60.48 |
| Indicator | NBTX | ZD |
|---|---|---|
| Relative Strength Index (RSI) | 31.35 | 47.72 |
| Support Level | $29.64 | $54.64 |
| Resistance Level | $35.38 | $57.48 |
| Average True Range (ATR) | 1.75 | 1.63 |
| MACD | -0.45 | -0.29 |
| Stochastic Oscillator | 0.55 | 12.31 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Ziff Davis Inc is a digital media and internet company operating a portfolio of brands across technology, shopping, gaming and entertainment, health and wellness, connectivity, and cybersecurity. The company has five reportable segments. The Technology & Shopping segment generates revenue from advertising and commerce content. The Gaming & Entertainment segment provides content, subscriptions, and digital storefront services. The Health & Wellness segment offers digital tools and content for health management. The Connectivity segment provides data and analytics solutions for network performance. The Cybersecurity & Martech segment delivers cloud-based software for security and marketing. It generates the majority of its revenue from the Health & Wellness segment.